Global Foot and Ankle Devices Market
Global Foot and Ankle Devices Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031
Foot and ankle devices refer to devices used for treating various foot and ankle injuries caused by orthopaedic disorders, as well as for replacing lost feet due to amputation, trauma, or accidents. These devices provide soft tissue protection, bone/joint stability, and control of body segment motion. Foot and ankle devices are being developed as a method of preventing people with sensory perception loss from sustaining a fall. Such devices are believed to work by reducing the likelihood of a fall by improving the balance and gait of the user.
Market Dynamics: Drivers & Restraints
Rise in the prevalence of rheumatoid arthritis
The foot and ankle devices market is growing due to the rise in foot and ankle disorders like osteoarthritis, rheumatoid arthritis, diabetic foot ulcers, and sports injuries, which often necessitate medical intervention.
For instance, according to the review study published by the Journal of Rheumatology in January 2023, the prevalence of inflammatory rheumatic diseases in adults in Germany has increased by 1% compared to previous years. The most common are rheumatoid arthritis and spondyloarthritis. The same source also stated that around 1.5 to 2.1 million people in Germany, or 2.2% to 3.0% of the country's population, have inflammatory rheumatic illnesses.
Furthermore, global foot and ankle devices are also driven by various other factors like a rise in the advancements in the devices, novel product launches by key players and others helping the market to grow during the forecast period.
Risks associated with the implants
Orthopaedic implants and devices pose risks such as discomfort during implant insertion and surgical site infections. They are often made of metal or alloys, which can cause allergies, infections, and metal sensitivity. These risks can lead to eczematous dermatitis, urinary tract infections, vasculitis, osteolysis, pain, and loosening of implanted metal hardware. Therefore, the use of these devices is limited due to these potential risks.
Segment AnalysisThe global foot and ankle devices market is segmented based on product type, application, end-user and region.
The arthroplasty devices from the product type segment accounted for approximately 41.7% of the foot and ankle devices market share
The arthroplasty devices from the product type segment accounted for approximately 41.7 %. Arthroplasty is a safe, effective procedure that helps people regain their mobility and relieves long-term pain. Most people who have a joint replacement have an increased quality of life because they can move better with less pain.
More commonly, Total Ankle Arthroplasty (TAA) and Total Talus Replacement (TTR) are used for patients with ankle degeneration and avascular necrosis of the talus, respectively. Ankle prosthesis and orthosis are also indicated for use with lower limb extremity amputations or locomotor disability, leading to the development of powered exoskeletons.
For instance, in December 2023, Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, stated its subsidiary, BlueOrtho, had received 510(k) clearance from the Food and Drug Administration for ExactechGPS Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA).
Geographical AnalysisNorth America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the factors like high incidence of injuries related to sports & physical activities and the presence of a large geriatric population pool. Also, novel product launches, FDA approvals and others help the region to have the highest market share during the forecast period.
For instance, in September 2023, MiRus stated a limited market release in the U.S. of its ATLAS MoRe Foot and Ankle Plating System, the thinnest foot and ankle plate on the market for the treatment of foot and ankle conditions. The molybdenum-rhenium alloy used in the plates allows for a dramatically smaller footprint of 1.0mm thickness without sacrificing performance.
Covid 19 Impact AnalysisThe pandemic has disrupted global supply chains, affecting the manufacturing and distribution of medical devices, including foot and ankle devices. The foot and ankle devices market relies on complex global supply chains for the procurement of raw materials, components, and finished products. The pandemic disrupted these supply chains due to lockdown measures and travel restrictions thereby resulting in delays in manufacturing, shortages, and increased costs, negatively impacting market demand.
Market SegmentationBy Product Type
• Arthroplasty Devices
• Ankle Replacement Systems
• Fracture Fixation Devices
• Plates, Screws
• Ankle Braces & Supports
• Implants
• Others
By Application
• Rheumatoid Arthritis
• Osteoarthritis
• Osteoporosis
• Hammertoe
• Others
By End-Users
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa
Competitive LandscapeThe major global players in the market include Optinova, Zeus Industrial Products, Saint-Gobain Performance Plastics, Teleflex, Nordson Corporation, Putnam Plastics, Raumedic, Teknor Apex, Freudenberg Medical, TE Connectivity and among others.
Key Developments In February 2024, Restor3d, Inc., a provider of patient-specific musculoskeletal implants based in Durham, North Carolina, USA, launched its additively manufactured foot and ankle products, the launch included the patient-specific Total Talus Replacement System and the line extension to the Kinos Axiom Total Ankle Replacement System, the Kinos X-Stem, Tall featuring a right-angle drill for controlled stem preparation.
In October 2023, the US Food and Drug Administration (FDA) cleared the TriLeap lower extremity anatomic plating system by Johnson & Johnson (J&J) company DePuy Synthes. The clearance for US-based DePuy Synthes means the plating system can be used by surgeons to stabilise bones during bunionectomies, osteotomies, and fusions or fractures of the foot or ankle.
Why Purchase the Report?• To visualize the global foot and ankle devices market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of foot and ankle devices market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global foot and ankle devices market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2023• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies